Effects of sample handling methods on substance P concentrations and immunoreactivity in bovine blood samples

Abstract

<p><strong>Objective</strong>—To determine the effects of protease inhibitors and holding times and temperatures before processing on the stability of substance P in bovine blood samples.</p> <p><strong>Samples</strong>—Blood samples obtained from a healthy 6-month-old calf.</p> <p><strong>Procedures</strong>—Blood samples were dispensed into tubes containing exogenous substance P and 1 of 6 degradative enzyme inhibitor treatments: heparin, EDTA, EDTA with 1 of 2 concentrations of aprotinin, or EDTA with 1 of 2 concentrations of a commercially available protease inhibitor cocktail. Plasma was harvested immediately following collection or after 1, 3, 6, 12, or 24 hours of holding at ambient (20.3° to 25.4°C) or ice bath temperatures. Total substance P immunoreactivity was determined with an ELISA; concentrations of the substance P parent molecule, a metabolite composed of the 9 terminal amino acids, and a metabolite composed of the 5 terminal amino acids were determined with liquid chromatography–tandem mass spectrometry.</p> <p><strong>Results</strong>—Regarding blood samples processed immediately, no significant differences in substance P concentrations or immunoreactivity were detected among enzyme inhibitor treatments. In blood samples processed at 1 hour of holding, substance P parent molecule concentration was significantly lower for ambient temperature versus ice bath temperature holding conditions; aprotinin was the most effective inhibitor of substance P degradation at the ice bath temperature. The ELISA substance P immunoreactivity was typically lower for blood samples with heparin versus samples with other inhibitors processed at 1 hour of holding in either temperature condition.</p> <p><strong>Conclusions and Clinical Relevance</strong>—Results suggested that blood samples should be chilled and plasma harvested within 1 hour after collection to prevent substance P degradation.</p>